EPCAM and non-small cell lung carcinoma: As an additional experiment, primary cells derived from a 76-year-old male patient, who underwent surgery for stage IA2 NSCLC, were co-stained for anti-CD44 and anti-EPCAM antibodies for selection by cell sorting.